The ADL recorded 151 antisemitic incidents in Washington, D.C., in 2024, a drop from the 171 incidents reported in 2023. However, both 2023 and 2024 represent large spikes compared to 2022, when ...

Addendum 2: ADCS-ADL vs. ADCS-ADL MCI Anavex's Blarcamesine and Biogen's Lecanemab cannot really be compared directly based on their ADCS-ADL score results.

Results for ADAS-Cog 14 and ADCS MCI-ADL in the low-tau subgroup were generally consistent with CDR-SB trends.

The Alzheimer’s Association released a new clinical practice guideline for the diagnostic evaluation and testing of Alzheimer disease (AD) and AD-related dementias (ADRD). A list of validated ...

This week, the Anti-Defamation League (ADL) is hosting its annual Never Is Now summit in New York City. But behind the polished speeches and corporate sponsorships, the truth is harder to stomach: … ...

Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

ADL faces backlash for defending Elon Musk’s raised-arm gesture After previously feuding with Musk, the pro-Israel group rushes to defend his gesture, which critics compared with a Nazi salute.

Subtle deficits were identified in advanced and instrumental ADL, which would generally go unnoticed, compromising quality of life and determining the risk of conversion to AD. Functionality may ...

Progression rates from MCI to dementia at 3 years were 61% with prodromal AD (any cognitive impairment, abnormal amyloid-β1-42 and tau or abnormal amyloid PET scan) versus 22% without prodromal ...